Table 1. Demographic data of participants.
| Variable/group | Schizophrenia | Controls | p |
|---|---|---|---|
| Number of participants | 29 | 32 | |
| Gender (male/female) | 11/18 | 10 /22 | .60 |
| Age (years) | 37.59±8.60 | 37.63±8.87 | .80 |
| Height (cm) | 162.36±6.82 | 163.08±8.82 | .06 |
| Weight (kg) | 73.19±14.90 | 74.14±14.92 | .62 |
| MMSE a score | 29.31±1.37 | 29.47±1.08 | .48 |
| Illness duration (yrs) | 13.72±6.92 | N/A | |
| BPRSb | 9.17±4.94 | N/A | |
| AIMSc | 3.34±3.43 | N/A | |
| Levels of antipsychotics (CPZEd, mg) | 377.43±260.36 | N/A | |
| Benzodiazepines (yes/no) | 11/18 | N/A | |
| Antidepressants (yes/no) | 7/22 | N/A |
aMMSE: Mini-mentalState Examination
bBPRS: Brief Psychiatric Rating Scale
cAIMS: Assessment of Involuntary Movement
dCPZE: Chlorpromazine equivalent dose